fashion -WSS

fashion

author：entertainment 2025-09-28 21:06:00 - browse：86597

The structure of a hospital bed at the abandoned, empty aisle of St Luke's Hospital — The former St Luke's Hospital in Pieta, Malta which was signed over to Vitals and later Steward Health Care on condition that it be redeveloped, shown here in a state of neglect and abandonment in January 2023. The Daphne Caruana Galizia Foundation/OCCRP

Protesters in the tiny Mediterranean nation of Malta converged last October on the 18th-century Baroque palace housing the prime minister’s offices chanting “thieves,” and unfurled a massive banner on the steps emblazoned with the words: “Bring back the €400 million now.”

The object of their furor wasn’t just the government. It was also Steward Health Care, the medical conglomerate that made Malta the first stop in its aggressive bid to expand internationally, even as its chain of hospitals in Massachusetts teeters on the verge of bankruptcy.

The €400 million figure is the amount Malta’s opposition party claims the government paid an affiliate of Steward and another company over an eight-year period to provide medical care to its citizens and transform three dilapidated state-owned hospitals into world-class institutions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Asbestos ban is immediate, but health effects will linger for decades

Wikipedia

entertainment

WSS

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Mirador, a new biotech startup, launches with $400 million

Food as medicine: Medically tailored meals may get standardized

States should stop sabotaging methadone treatment reform

Why the world’s most expensive drug might be worth the price

Will generative AI in health care meet the fate of IBM's Dr. Watson?

hotspot

fashion

Wikipedia

Anesthesiologist group: stop taking Ozempic before surgery

With Wegovy coverage, Medicare patients may face high costs

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Biotech investment managers search for lucrative opportunities

Peter Hotez and the public health issue of online harassment

Testing GLP

DIEP, the 'gold standard' of breast reconstruction, is under threat

Supreme Court mifepristone arguments center on docs' right to sue

hotspot

This gene therapy has record $4.25 million price. It's saved children.

Texas board proposes rules on abortion law emergency exemption

Decaf coffee targeted by food safety group under obscure FDA rule

Texas board proposes rules on abortion law emergency exemption

Readout Newsletter: Illumina, CRISPR, Regeneron

Merck drug for rare lung condition set for approval in U.S.

Wikipedia

focus

entertainment

focus